FLT3 and acute myeloid leukemia: Preclinical study showed that FLT3-inhibitor can upregulate the surface expression of FLT3 specifically on FLT3-ITD+ AML cells and enhance the recognition of FLT3-CAR T-cells in vitro and in vivo.